glp-1 and type 2 diabetes receptor agonists in the treatment of – state-of-the-art GLP-1 Receptor Agonist Shortage: Challenges

Effects of glucagon-like peptide-1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

Compounded microdosing is a good interim solution, but patients considering this option need to be very cautious on where the medication is sourced. Experts also stressed the importance of having medical oversight while using GLP-1 medications

The providers who work through telehealth platforms are accustomed to ongoing communication with their patients and welcome your engagement

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

While small molecules like nicotine or estrogen can be absorbed via a patch, GLP-1 molecules are roughly ten times larger than the limit for skin absorption